drugset / Trial / NCT04073173

Stress Assessment With and Without Analgesia During Surfactant Therapy in Preterm Infants.

NCT04073173

RandomizedParallel-groupDouble-blindTreatment

Summary

This study will compare stress, changes in oxygenation and oxidative damage in preterm infants with respiratory distress syndrome (RDS) randomized to receive or not remifentanil as an analgesic drug during the administration of porcine surfactant (poractant alfa, Curosurf®) through the traditional (INSURE) or the less invasive (LISA) method.

Timeline

Start
2020-11-01
Primary completion
2022-10-31
Completion
2022-10-31

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Remifentanil Small molecule 0.5 ug/kg
Subject Remifentanil Small molecule 2 ug/kg